Day One Biopharmaceuticals Long Term Deferred Assets (Quarterly) Analysis

Day One Biopharmaceuticals, Inc. (DAWN)

12.06 -0.06 (-0.45%) USD | NASDAQ | Jan 21, 16:00

12.06 0.00 (0.00%) After-Hours: 16:25

View Long Term Deferred Assets (Quarterly) for DAWN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Mersana Therapeutics, Inc. (DELISTED)	--
iRhythm Holdings, Inc.	--
Perspective Therapeutics, Inc.	--
Electromed, Inc.	Upgrade
InfuSystem Holdings, Inc.	Upgrade